Current role
Biotechnology · Healthcare
Board Member
2019-01-01–present
Carrie S. Cox
Board Member
Cartesian Therapeutics, Inc. (RNAC)Equibles does not estimate personal net worth.
Get an email with a short summary when Cartesian Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get RNAC alertsAbout Carrie S. Cox
Carrie S. Cox is recorded as Board Member at Cartesian Therapeutics, Inc. (RNAC) since June 14, 2024. Cartesian Therapeutics, Inc. reported in an 8-K filed October 30, 2025 that Carrie S. Cox resigned as member of the Board of Directors, effective October 29, 2025. Cartesian Therapeutics, Inc. reported in an 8-K filed June 17, 2024 that Carrie S. Cox was appointed Class II Director, effective June 14, 2024. Cartesian Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Cartesian Therapeutics, Inc. includes Carsten Brunn (CEO and Board Member), Carsten Brunn, Ph.D. (Chairman), Blaine Davis (CFO and Chief Accounting Officer) and 7 others.
“on October 29, 2025, Carrie S. Cox, a member of the Board of Directors (the “Board”) of Cartesian Therapeutics, Inc. (the “Company”), notified the Company of her resignation from the Board, effective immediately.”
“Based on the votes set forth above, each director nominee was duly elected to serve until the Company's 2027 Annual Meeting of Stockholders, and until their respective successors have been duly elected and qualified.”
Affiliation history
-
Current
2024-06-14–present
-
2019-01-01–2025-10-29
-
Start not stated–2025-10-29
Company network
Leadership on record at Cartesian Therapeutics, Inc.
- Carsten Brunn CEO, Board Member
- Carsten Brunn, Ph.D. Chairman
- Blaine Davis CFO, Chief Accounting Officer
- Kevin Tan CFO
- Metin Kurtoglu COO
- Metin Kurtoglu, M.D., Ph.D. COO
- June Seymour Chief Accounting Officer
- Adrian Bot Board Member
- Adrian Bot, M.D., Ph.D. Board Member
- Kemal Malik Board Member